314 related articles for article (PubMed ID: 7684512)
21. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.
Adachi JD; Bensen WG; Bianchi F; Cividino A; Pillersdorf S; Sebaldt RJ; Tugwell P; Gordon M; Steele M; Webber C; Goldsmith CH
J Rheumatol; 1996 Jun; 23(6):995-1000. PubMed ID: 8782129
[TBL] [Abstract][Full Text] [Related]
23. Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
Malavolta N; Zanardi M; Veronesi M; Ripamonti C; Gnudi S
Int J Tissue React; 1999; 21(2):51-9. PubMed ID: 10568224
[TBL] [Abstract][Full Text] [Related]
24. Calcium- and vitamin D3-fortified milk reduces bone loss at clinically relevant skeletal sites in older men: a 2-year randomized controlled trial.
Daly RM; Brown M; Bass S; Kukuljan S; Nowson C
J Bone Miner Res; 2006 Mar; 21(3):397-405. PubMed ID: 16491287
[TBL] [Abstract][Full Text] [Related]
25. Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial.
McDonald CF; Zebaze RM; Seeman E
Osteoporos Int; 2006 Oct; 17(10):1546-51. PubMed ID: 16832714
[TBL] [Abstract][Full Text] [Related]
26. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis.
Adachi JD; Bensen WG; Bell MJ; Bianchi FA; Cividino AA; Craig GL; Sturtridge WC; Sebaldt RJ; Steele M; Gordon M; Themeles E; Tugwell P; Roberts R; Gent M
Br J Rheumatol; 1997 Feb; 36(2):255-9. PubMed ID: 9133941
[TBL] [Abstract][Full Text] [Related]
27. Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.
Cranney A; Welch V; Adachi JD; Homik J; Shea B; Suarez-Almazor ME; Tugwell P; Wells G
Cochrane Database Syst Rev; 2000; 2000(2):CD001983. PubMed ID: 10796457
[TBL] [Abstract][Full Text] [Related]
28. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate.
Bianda T; Linka A; Junga G; Brunner H; Steinert H; Kiowski W; Schmid C
Calcif Tissue Int; 2000 Aug; 67(2):116-21. PubMed ID: 10920215
[TBL] [Abstract][Full Text] [Related]
29. Effect of calcitriol on bone loss after cardiac or lung transplantation.
Sambrook P; Henderson NK; Keogh A; MacDonald P; Glanville A; Spratt P; Bergin P; Ebeling P; Eisman J
J Bone Miner Res; 2000 Sep; 15(9):1818-24. PubMed ID: 10977001
[TBL] [Abstract][Full Text] [Related]
30. Combined treatment with calcitonin and 1,25-dihydroxyvitamin D3 for osteoporosis in women.
Eriksson SA; Lindgren JU
Calcif Tissue Int; 1993 Jul; 53(1):26-8. PubMed ID: 8348381
[TBL] [Abstract][Full Text] [Related]
31. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group.
Roux C; Oriente P; Laan R; Hughes RA; Ittner J; Goemaere S; Di Munno O; Pouillès JM; Horlait S; Cortet B
J Clin Endocrinol Metab; 1998 Apr; 83(4):1128-33. PubMed ID: 9543129
[TBL] [Abstract][Full Text] [Related]
32. Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases.
Loddenkemper K; Grauer A; Burmester GR; Buttgereit F
Clin Exp Rheumatol; 2003; 21(1):19-26. PubMed ID: 12673885
[TBL] [Abstract][Full Text] [Related]
33. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
Reginster JY; Denis D; Deroisy R; Lecart MP; De Longueville M; Zegels B; Sarlet N; Noirfalisse P; Franchimont P
J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
[TBL] [Abstract][Full Text] [Related]
34. Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis.
Tekeoğlu I; Adak B; Budancamanak M; Demirel A; Ediz L
Rheumatol Int; 2005 Dec; 26(2):157-61. PubMed ID: 15660234
[TBL] [Abstract][Full Text] [Related]
35. Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation.
Torres A; García S; Gómez A; González A; Barrios Y; Concepción MT; Hernández D; García JJ; Checa MD; Lorenzo V; Salido E
Kidney Int; 2004 Feb; 65(2):705-12. PubMed ID: 14717945
[TBL] [Abstract][Full Text] [Related]
36. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
Frediani B; Falsetti P; Baldi F; Acciai C; Filippou G; Marcolongo R
Bone; 2003 Oct; 33(4):575-81. PubMed ID: 14555261
[TBL] [Abstract][Full Text] [Related]
37. Salmon calcitonin in the prevention of bone loss at perimenopause.
Arnala I; Saastamoinen J; Alhava EM
Bone; 1996 Jun; 18(6):629-32. PubMed ID: 8806006
[TBL] [Abstract][Full Text] [Related]
38. [Use of salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis in bullous diseases].
Cappio F; Colombo MD; Caputo R
G Ital Dermatol Venereol; 1990 Dec; 125(12):LXI-LXIV. PubMed ID: 2091976
[TBL] [Abstract][Full Text] [Related]
39. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study.
Bernstein CN; Seeger LL; Anton PA; Artinian L; Geffrey S; Goodman W; Belin TR; Shanahan F
Aliment Pharmacol Ther; 1996 Oct; 10(5):777-86. PubMed ID: 8899087
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of calcitriol in treating glucocorticoidinduced osteoporosis in patients with nephrotic syndrome: an open-label, randomized controlled study.
Chen Y; Wan JX; Jiang DW; Fu BB; Cui J; Li GF; Chen CM
Clin Nephrol; 2015 Nov; 84(5):262-9. PubMed ID: 26396095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]